Combined Adductoplasty™ and Lapiplasty® Surgery for Bunions
(MTA3D Trial)
Trial Summary
What is the purpose of this trial?
Prospective, multicenter, unblinded study to evaluate outcomes of the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure for patients in need of metatarsus adductus and hallux valgus correction. Up to 80 subjects will be treated in this study at up to 13 clinical sites. Patients 14 years of age or older with symptomatic metatarsus adductus and hallux valgus will be eligible to participate based on the inclusion and exclusion criteria defined in the study protocol.
Do I need to stop taking my current medications for the trial?
The trial protocol does not specify if you need to stop taking your current medications. However, if you are currently taking oral steroids, rheumatoid biologics, or immunosuppressant drugs, you may not be eligible to participate.
What data supports the effectiveness of the treatment Combined Adductoplasty™ and Lapiplasty® Surgery for Bunions?
The research suggests that correcting combined foot deformities, like metatarsus adductus and hallux valgus, using surgical techniques similar to those in the Combined Adductoplasty™ and Lapiplasty® procedures, can lead to good clinical and radiographic outcomes, reducing the chance of recurrence.12345
How is the Combined Adductoplasty™ and Lapiplasty® treatment for bunions different from other treatments?
The Combined Adductoplasty™ and Lapiplasty® treatment is unique because it combines two surgical procedures to correct bunions by addressing both the alignment of the toe and the underlying bone structure, potentially offering a more comprehensive correction compared to traditional bunion surgeries that may only focus on one aspect.678910
Research Team
Mark Easley, MD
Principal Investigator
Duke University
Paul Dayton, DPM
Principal Investigator
Foot and Ankle Center of Iowa
Eligibility Criteria
This trial is for individuals aged 14 to 65 with symptomatic metatarsus adductus and hallux valgus, which are conditions affecting the alignment of the foot and big toe. Participants must have specific angles of deformity, be able to follow post-op care instructions, complete questionnaires, not be pregnant or planning other foot surgeries soon. Exclusions include severe arthritis in certain joints, very high BMI, diabetes, neuropathy among others.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo the Adductoplasty™ Procedure in combination with the Lapiplasty® Procedure for correction of metatarsus adductus and hallux valgus
Initial Recovery
Participants begin weight-bearing in a boot and start recovery
Follow-up
Participants are monitored for safety, effectiveness, and recurrence of hallux valgus deformity
Long-term Follow-up
Participants are monitored for long-term outcomes including quality of life and clinical complications
Treatment Details
Interventions
- Combined Adductoplasty™ and Lapiplasty®
Combined Adductoplasty™ and Lapiplasty® is already approved in United States for the following indications:
- Metatarsus adductus correction
- Hallux valgus correction
Find a Clinic Near You
Who Is Running the Clinical Trial?
Treace Medical Concepts, Inc.
Lead Sponsor